Filings for Rule Number 5160-4-12

Title Immunizations, injections and infusions (including trigger-point injections), skin substitutes, and provider-administered pharmaceuticals.
Agency Ohio Department of Medicaid
Division
Contact Tommi Potter
Phone 614-752-3877

Actions

Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR Documents
No Current Actions
Title File Date Action Type Class Hearing Eff Date Exp Date FYR Documents
Immunizations, injections and infusions (including trigger-point injections), skin substitutes, and provider-administered pharmaceuticals. 02/11/2022 Final File Amendment 119.03 03/01/2022 Y
Rule Body
Immunizations, injections and infusions (including trigger-point injections), skin substitutes, and provider-administered pharmaceuticals. 11/30/2021 Original File Amendment 119.03 01/03/2022 Y
Public Notice
RSFA Analysis
Rule Body
Hearing Summary Report
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 10/12/2017 Final File Amendment 119.03 11/01/2017 Y
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 08/25/2017 Refile Amendment 119.03 Y
RSFA Analysis
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 05/24/2017 Original File Amendment 119.03 06/26/2017 Y
Public Notice
RSFA Analysis
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 10/05/2015 Final File Rescission 119.03 11/01/2015 Y
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 10/05/2015 Final File New 119.03 11/01/2015 N
Rule Body
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 08/20/2015 Revise New 119.03 N
RSFA Analysis
Rule Body
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 07/17/2015 Original File New 119.03 08/17/2015 N
Public Notice
RSFA Analysis
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 07/17/2015 Original File Rescission 119.03 08/17/2015 Y
Public Notice
RSFA Analysis
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
5160-4-12 was re-numbered from 5101:3-4-12 on 06/09/2014
Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR
Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR
Immunizations, injections and infusions (including trigger-point injections), skin substitutes, and provider-administered pharmaceuticals. 02/11/2022 Final File Amendment 119.03 03/01/2022 Y
Immunizations, injections and infusions (including trigger-point injections), skin substitutes, and provider-administered pharmaceuticals. 11/30/2021 Original File Amendment 119.03 01/03/2022 Y
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 10/12/2017 Final File Amendment 119.03 11/01/2017 Y
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 08/25/2017 Refile Amendment 119.03 Y
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 05/24/2017 Original File Amendment 119.03 06/26/2017 Y
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 10/05/2015 Final File Rescission 119.03 11/01/2015 Y
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 10/05/2015 Final File New 119.03 11/01/2015 N
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 08/20/2015 Revise New 119.03 N
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 07/17/2015 Original File New 119.03 08/17/2015 N
Immunizations, injections and infusions (including trigger-point injections), and provider-administered pharmaceuticals. 07/17/2015 Original File Rescission 119.03 08/17/2015 Y
5160-4-12 was re-numbered from 5101:3-4-12 on 06/09/2014